British Journal of Cancer publishes first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK.
British Journal of Cancer publishes NET Patient Foundation’s research into impact of neuroendocrine morphology on cancer outcome and stage at diagnosis NET Patient Foundation in collaboration with Public Health England have undertaken the first in-depth epidemiological characterisation of Neuroendocrine Tumours in the UK to identify areas of unmet need with an aim to inform service improvement.
Recent News
PERT Shortages Survey
We know how stressful the ongoing PERT shortages are for those affected by neuroendocrine cancer (NET & NEC), pancreatic cancer (PDAC), pancreatitis, and cystic fibrosis. As charities, we are committed to monitoring the situation and sustaining pressure for this...
Breakthrough Research Paves Way for Personalised Treatment in Lung Neuroendocrine Cancer
Discover how breakthrough lung research from Dr Jules Derks and Maastricht University is advancing personalised treatment for Lung Neuroendocrine Tumours (Lung NETs), offering new hope through a simple tool that could transform targeted therapies.
Neuroendocrine Cancer in the Daily Express – ‘I had no idea I was dying – and then I found out on the NHS app’
We are delighted to support the Daily Express Cancer Care campaign ensuring that all cancer patients get access to mental health support both during and after their treatment. Neuroendocrine Cancer UK have had their 3rd article in support of this campaign...